MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617090139 A) filed by Genequantum Healthcare Suzhou Co. , Ltd.; and Aimed Bio Inc. on July 24, 2026, for A Pharmaceutical Composition Of Anti-Fgfr3 Antibody Drug Conjugate And Applications Thereof.
Inventors include Qin, Gang; Song, Paul H.; Min, Byeongkwi; and Li, Xuesong.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Provided is a pharmaceutical composition comprising conjugates containing anti-FGFR3 antibodies and linker-payloads, the corresponding pharmaceutical composition, preparing process and use thereof.
Disclaimer: Curated by HT Syndication....